Restoration of renal perfusion and function in chronic kidney disease

Asian Biomedicine

Volumn 6, Issue 1, 2012, Pages 95-98

  Futrakul, Narisa ^a   Futrakul, Prasit ^a   Sirisalipoch, Sasitorn ^a   Chanakul, Ankanee ^a   Deekajorndech, Tawatchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Chronic kidney disease; Creatinine clearance; FE Mg; Renal hemodynamics; Vascular repair; Vasodilators

Indexed keywords

CREATININE; ENALAPRIL MALEATE; LOSARTAN; TELMISARTAN;

ADULT; AGED; ARTICLE; CAPILLARY FLOW; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; MAGNESIUM EXCRETION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 84871644901     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.5372/1905-7415.0601.132     Document Type: Article

References (18)

1. Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A, Watanapenphaibul K, et al. Peritubular capillary flow determines tubulointerstitial fibrosis in idiopathic nephritic syndrome. Ren Fail. 2000; 22: 329-35. (Pubitemid 30347065)
2. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002; 13:806-16. (Pubitemid 34183950)
3. Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007; 1:33-44.
4. Coresh J, Astor BC, Green T, Ehnogan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis. 2003; 41:1-13.
5. Obrader GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol. 2002; 22:441-8. (Pubitemid 35351257)
6. Ruggenenti P, Schicppati A, Remuzzi G. Progression, remission, regression of chronic kidney diseases. Lancet 2001; 357:1601-8. (Pubitemid 32488830)
7. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemoeheol Microcirc. 2008; 38:201-7. (Pubitemid 351185407)
8. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy. Ren Fail. 2009; 31:207-10.
9. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol. 2009; 20:239-44.
10. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR2 in experimental diabetes. Diabetes. 1999; 48: 2229-39. (Pubitemid 29521855)
11. Nakagawa T, Kosugi T, Hanada M, Rivard CJ, Long DA. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009; 58:1471-8.
12. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagna PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type 2 diabetics exhibit impaired, proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002; 106:2781-6. (Pubitemid 35396976)
13. Satcholl SC, Anderson KL, Mathieson PW. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol. 2004; 15:566-74. (Pubitemid 38294786)
14. Yao D, Taquachi T, Matsumura T, Parstell R, Edelstein D, Giardino I, et al. High glucose increases angiopoietin 2 transcription in microvascular endothelial cells through methylglyoxal modification of in Sin 3A. J Biol Chem. 2007; 282; 31038-45. (Pubitemid 350035169)
15. Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009; 31: 538-43.
16. Futrakul P, Yenrusi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular functional tubulointerstitial disease. Am J Kidney Dis. 1999; 33:886-91.
17. Futrakul N, Futrakul P, Siriviriyakul P. Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis. Clin Hemorrheo Microcirc. 2004; 31:197-205. (Pubitemid 39362720)
18. Futrakul N, Futrakul P. Improved vascular repair is relevant to enhanced renal function with vasodilators in early stage of chronic kidney disease. Asian Biomed. 2010; 4:153-7.